137 related articles for article (PubMed ID: 37073700)
1. Endoscopic management of gastric neuroendocrine tumors: an analysis of 50 cases.
Varas Lorenzo MJ; Abad Belando R; Muñoz Agel F; Gornals Soler JB
Rev Esp Enferm Dig; 2024 Jan; 116(1):47-48. PubMed ID: 37073700
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.
Chen X; Li B; Wang S; Yang B; Zhu L; Ma S; Wu J; He Q; Zhao J; Zheng Z; Li S; Wang T; Liang L
Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980
[No Abstract] [Full Text] [Related]
3. Management and endoscopic treatment of rectal neuroendocrine tumors.
Varas Lorenzo M; Abad Belando R
Rev Esp Enferm Dig; 2023 Aug; 115(8):470-471. PubMed ID: 37204098
[TBL] [Abstract][Full Text] [Related]
4. Synchronous Triple Gastric Cancer Incorporating Mixed Adenocarcinoma and Neuroendocrine Tumor Completely Resected with Endoscopic Submucosal Dissection.
Kubo K; Kimura N; Mabe K; Nishimura Y; Kato M
Intern Med; 2018 Oct; 57(20):2951-2955. PubMed ID: 29780136
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of endoscopic submucosal dissection for upper gastrointestinal submucosal tumors treatment and value of endoscopic ultrasonography in pre-operation assess and post-operation follow-up: a prospective study of 224 cases in a single medical center.
He G; Wang J; Chen B; Xing X; Wang J; Chen J; He Y; Cui Y; Chen M
Surg Endosc; 2016 Oct; 30(10):4206-13. PubMed ID: 26823060
[TBL] [Abstract][Full Text] [Related]
6. Duodenal neuroendocrine tumors: analysis of 20 cases and endoscopic treatment.
Varas Lorenzo M; Abad Belando R; Muñoz Agel F; Gornals JB
Rev Esp Enferm Dig; 2023 Feb; 115(2):104-105. PubMed ID: 36645067
[TBL] [Abstract][Full Text] [Related]
7. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis.
Tsolakis AV; Ragkousi A; Vujasinovic M; Kaltsas G; Daskalakis K
World J Gastroenterol; 2019 Sep; 25(35):5376-5387. PubMed ID: 31558880
[TBL] [Abstract][Full Text] [Related]
8. The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors.
Esposito G; Dell'Unto E; Ligato I; Marasco M; Panzuto F
Expert Rev Gastroenterol Hepatol; 2023; 17(8):785-793. PubMed ID: 37497604
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of endoscopic resection for type I gastric neuroendocrine tumors.
Uygun A; Kadayifci A; Polat Z; Yilmaz K; Gunal A; Demir H; Bagci S
J Surg Oncol; 2014 Feb; 109(2):71-4. PubMed ID: 24165913
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Challenges for Gastric Neuroendocrine Neoplasms: Take It or Leave It?
Cavalcoli F; Gallo C; Coltro LA; Rausa E; Cantù P; Invernizzi P; Massironi S
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893475
[No Abstract] [Full Text] [Related]
11. Double-band ligation-assisted endoscopic submucosal resection for type 1 gastric neuroendocrine tumor with type A gastritis.
Deng C; Wu S; Xu F; Lv L; Zhou Z; He S
Endoscopy; 2022 Dec; 54(12):E724-E725. PubMed ID: 35272372
[No Abstract] [Full Text] [Related]
12. Double-endoscope assisted endoscopic submucosal dissection for treating gastric neuroendocrine tumor.
Lu J; Wang P; Ji R; Lu X
Endoscopy; 2022 Jul; 54(7):E342-E343. PubMed ID: 34282584
[No Abstract] [Full Text] [Related]
13. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
[TBL] [Abstract][Full Text] [Related]
14. Recurrent gastric neuroendocrine tumors treated with total gastrectomy.
Jung M; Kim JW; Jang JY; Chang YW; Park SH; Kim YH; Kim YW
World J Gastroenterol; 2015 Dec; 21(46):13195-200. PubMed ID: 26675502
[TBL] [Abstract][Full Text] [Related]
15. Gastric perforation during ligation-assisted endoscopic mucosal resection of a neuroendocrine tumor: banding without resection may be a safer option.
Bas-Cutrina F; Ballester-Clau R; González-Huix F; Gornals JB
Endoscopy; 2020 Oct; 52(10):E370-E371. PubMed ID: 32219785
[No Abstract] [Full Text] [Related]
16. [Endoscopic Treatment Outcome of Rectal Neuroendocrine Tumors Removed by Ligation-assisted Endoscopic Submucosal Resection].
Gu MG; Lee SH
Korean J Gastroenterol; 2018 Sep; 72(3):128-134. PubMed ID: 30270594
[TBL] [Abstract][Full Text] [Related]
17. Type 3 gastric neuroendocrine tumor with unique endoscopic features.
Kawasaki K; Nakamura S; Sugai T; Matsumoto T
Dig Liver Dis; 2016 Oct; 48(10):1264. PubMed ID: 27476464
[No Abstract] [Full Text] [Related]
18. Selective Resection of Type 1 Gastric Neuroendocrine Neoplasms and the Risk of Progression in an Endoscopic Surveillance Programme.
Chin JL; O'Connell J; Muldoon C; Swan N; Reynolds JV; Ravi N; Geoghegan J; Conlon KC; O'Shea D; O'Toole D
Dig Surg; 2021; 38(1):38-45. PubMed ID: 33260173
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of modified endoscopic mucosal resection for rectal neuroendocrine tumors: a meta-analysis.
Zheng JC; Zheng K; Zhao S; Wang ZN; Xu HM; Jiang CG
Z Gastroenterol; 2020 Feb; 58(2):137-145. PubMed ID: 32050284
[TBL] [Abstract][Full Text] [Related]
20. Implementation of Endoscopic Submucosal Dissection for Gastric Lesions in Norway.
Rushfeldt C; Aabakken L
Scand J Surg; 2016 Jun; 105(2):90-6. PubMed ID: 26250354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
